Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population

Peritoneal Dialysis International

Volumn 32, Issue 1, 2012, Pages 86-93

  Ng, Yee Yung ^a   Wu, Shiao Chi ^a   Lin, Hong Da ^a   Hu, Fen Hsiang ^b   Hou, Chun Cheng ^c   Chou, Yea Yun ^a   Chiu, Shih Min ^a   Sun, Ya Hui ^a   Cho, Sandy Shan Ying ^a   Yang, Wu Chang ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Wei Gong Memorial Hospital   (Taiwan)

^c MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

Cardiovascular disease; Cerebrovascular disease; Continuous ambulatory peritoneal dialysis; Erythropoietin; Subclinical hypothyroidism

Indexed keywords

ERYTHROPOIETIN; LEVOTHYROXINE SODIUM; LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGED; ANEMIA; ANTIBODY BLOOD LEVEL; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; EUTHYROIDISM; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX; SUBTOTAL THYROIDECTOMY; THYROID DISEASE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TAIWAN; THYROID DISEASES; THYROTROPIN; THYROXINE;

EID: 84863042250     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00202     Document Type: Article

References (45)

1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526-34.
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). JClin Endocrinol Metab 2002; 87:489-99.
3. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43:55-68.
4. Chuang CC, Wang ST, Wang PW, Yu ML. Prevalence study of thyroid dysfunction in the elderly of Taiwan. Gerontology 1998; 44:162-7.
5. Lim VS. Thyroid function in patients with chronic renal failure. Am JKidney Dis 2001; 38(Suppl 1):S80-4.
6. Lin CC, Chen TW, Ng YY, Chou YH, Yang WC. Thyroid dysfunction and nodular goiter in hemodialysis and peritoneal dialysis patients. Perit Dial Int 1998; 18:516-21.
7. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocr Rev 1996; 17:45-63.
8. Rao MB, Bay WH, George JM, Hebert LA. Primary hypothyroidism in chronic renal failure. Clin Nephrol 1986; 25:11-14.
9. Diez JJ, Iglesias P, Selgas R. Pituitary dysfunctions in uremic patients undergoing peritoneal dialysis: a cross sectional descriptive study. Adv Perit Dial 1995; 11:218-24.
10. Xess A, Gupta A, Kumar U, Sharma HP, Prasad KM. Evaluation of thyroid hormones in chronic renal failure. Indian JPathol Microbiol 1999; 42:129-33.
11. Maues MG, Santos SF, Filho HP, Lugon JR, Cruz VP, Sampaio JC, et al. Thyroid hormone losses in CAPD. Perit Dial Int 1995; 15:266-9.
12. Sanai T, Inoue T, Okamura K, Sato K, Yamamoto K, Abe T, et al. Reversible primary hypothyroidism in Japanese patients undergoing maintenance hemodialysis. Clin Nephrol 2008; 69:107-13.
13. Wiederkehr MR, Kalogiros J, Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 2004; 19:1190-7.
14. Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Miura S. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Exp Clin Endocrinol Diabetes 2002; 110:408-15.
15. Konno N, Makita H, Yuri K, Iizuka N, Kawasaki K. Association between dietary iodine intake and prevalence of subclinical hypothyroidism in the coastal regions of Japan. JClin Endocrinol Metab 1994; 78:393-7.
16. Robey C, Shreedhar K, Batuman V. Effects of chronic peritoneal dialysis on thyroid function tests. Am JKidney Dis 1989; 13:99-103.
17. Gardner DF, Mars DR, Thomas RG, Bumrungsup C, Misbin RI. Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am JKidney Dis 1986; 7:471-6.
18. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. JClin Endocrinol Metab 2004; 89:3365-70.
19. Monzani F, Di Bello V, Caraccio N, Bertini A, Giorgi D, Giusti C, et al. Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. JClin Endocrinol Metab 2001; 86:1110-15.
20. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 2005; 165:2467-72.
21. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med 2008; 148:832-45.
22. Squizzato A, Gerdes VE, Brandjes DP, Buller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005; 36:2302-10.
23. Karakurum Goksel B, Karatas M, Nebioglu A, Sezgin N, Tan M, Seydaoglu G, et al. Subclinical hypothyroidism, hyperhomocysteinemia and dyslipidemia: investigating links with ischemic stroke in Turkish patients. Neurol Res 2007; 29:871-6.
24. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21:637-76.
25. Nakatani T, Naganuma T, Uchida J, Masuda C, Wada S, Sugimura T, et al. Silent cerebral infarction in hemodialysis patients. Am JNephrol 2003; 23:86-90.
26. Koren-Morag N, Goldbourt U, Tanne D. Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology 2006; 67:224-8.
27. Toyoda K, Fujii K, Ando T, Kumai Y, Ibayashi S, Iida M. Incidence, etiology, and outcome of stroke in patients on continuous ambulatory peritoneal dialysis. Cerebrovasc Dis 2004; 17:98-105.
28. Patient mortality and survival. United States Renal Data System. Am JKidney Dis 1998; 32(Suppl 1):S69-80.
29. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. JAm Soc Nephrol 1998; 9(Suppl):S16-23.
30. Kang EW, Nam JY, Yoo TH, Shin SK, Kang SW, Han DS, et al. Clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis patients. Am JNephrol 2008; 28:908-13.
31. Kasagi K, Takahashi N, Inoue G, Honda T, Kawachi Y, Izumi Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid 2009; 19:937-44.
32. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA2004; 291:228-38.
33. Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int 2005; 67:1047-52.
34. Descamps-Latscha B, Herbelin A, Nguyen AT, Zingraff J, Jungers P, Chatenoud L. Immune system dysregulation in uremia. Semin Nephrol 1994; 14:253-60.
35. Girndt M. Humoral immune responses in uremia and the role of IL-10. Blood Purif 2002; 20:485-8.
36. Sezer S, Ozdemir FN, Guz G, Arat Z, Colak T, Sengul S, et al. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplant Proc 2000; 32:607-8.
37. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001; 78:S206-11.
38. Chang PM, Ng YY. Amiodarone-induced hypothyroidism with EPO-resistant anemia in a patient with chronic renal failure. JChin Med Assoc 2008; 71:576-8.
39. Dilek M, Akpolat T, Cengiz K. Hypothyroidism as a cause of resistance to erythropoietin. Nephron 2002; 92:248.
40. Sungur C, Erbas T, Akpolat T, Arik N, Yasavul U, Turgan C, et al. Resistance to human recombinant erythropoietin in hypothyroidism. Acta Haematol 1992; 88:162.
41. Dorr M, Empen K, Robinson DM, Wallaschofski H, Felix SB, Volzke H. The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area. Eur JEndocrinol 2008; 159:145-52.
42. Rodondi N, Newman AB, Vittinghoff E, de Rekeneire N, Satterfield S, Harris TB, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med 2005; 165:2460-6.
43. Baek JH, Chung PW, Kim YB, Moon HS, Suh BC, Jin DK, et al. Favorable influence of subclinical hypothyroidism on the functional outcomes in stroke patients. Endocr J2010; 57:23-9.
44. Simonsick EM, Newman AB, Ferrucci L, Satterfield S, Harris TB, Rodondi N, et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 2009; 169:2011-17.
45. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29:76-131.